ClinicalTrials.Veeva

Menu
C

Cardinal Santos Medical Center | Department of Internal Medicine

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Trastuzumab
Relamorelin
Pertuzumab
Taxane
Bevacizumab
Hydroxychloroquine
Lopinavir
Platinum
/Pertuzumab
Ritonavir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

This is a global, multicenter, open-label safety extension study. Participants receiving single-agent trastuzumab emtansine or trastuzumab emtansine...

Active, not recruiting
Neoplasm Metastasis
Drug: Trastuzumab
Drug: Pertuzumab

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy...

Enrolling
Peritoneal Cancer
Fallopian Tube Cancer
Drug: Bevacizumab
Drug: Mirvetuximab soravtansine plus Bevacizumab

Trial sponsors

Allergan logo
Boehringer Ingelheim logo
Genentech logo
IMUNON logo
ImmunoGen logo
Roche logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems